Serum albumin: A prognostic indicator in patients with colorectal cancer

S. D. Heys*, L. G. Walker, D. J. Deehan, O. E. Eremin

*Corresponding author for this work

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Various prognostic factors for survival have been identified in patients with colorectal cancer. However, although it has been suggested that the pre-treatment serum albumin concentration is a prognostic indicator in certain malignant diseases (melanoma, prostate cancer, leukaemia), its value in patients with colorectal cancer remains unclear. This study investigated the prognostic value of serum albumin in this patient group. A total of 431 patients presenting to the Professorial Surgical Unit between 1972 and 1985 were analysed in this study. Using the Cox proportional hazard model, age, tumour stage (Dukes' stage) and tumour differentiation were shown to be independent prognostic factors for survival in patients with localized colorectal cancer. In addition, the pre-treatment serum albumin concentration was found to be an independent prognostic indicator. This is the first such documentation for patients with 'curable' colorectal cancer.

Original languageEnglish
Pages (from-to)163-168
Number of pages6
JournalJournal of the Royal College of Surgeons of Edinburgh
Volume43
Issue number3
Publication statusPublished - 1 Jul 1998

Keywords

  • Albumin
  • Colorectal cancer
  • Survival

Fingerprint Dive into the research topics of 'Serum albumin: A prognostic indicator in patients with colorectal cancer'. Together they form a unique fingerprint.

  • Cite this

    Heys, S. D., Walker, L. G., Deehan, D. J., & Eremin, O. E. (1998). Serum albumin: A prognostic indicator in patients with colorectal cancer. Journal of the Royal College of Surgeons of Edinburgh, 43(3), 163-168.